Changes in Stress, Substance Use and Medication Beliefs are Associated with Changes in Adherence to HIV Antiretroviral Therapy

被引:0
作者
Tyler French
James Tesoriero
Bruce Agins
机构
[1] AIDS Institute,Office of Program Evaluation and Research
[2] New York State Department of Health,Office of the Medical Director
[3] AIDS Institute,undefined
[4] New York State Department of Health,undefined
来源
AIDS and Behavior | 2011年 / 15卷
关键词
Treatment adherence; Antiretroviral therapy; ARV; HIV; AIDS; Predictors; Longitudinal study;
D O I
暂无
中图分类号
学科分类号
摘要
Stress, substance use and medication beliefs are among the most frequently cited barriers to HIV treatment adherence. This study used longitudinal techniques to examine the temporal relationship between these barriers and adherence among clients attending treatment adherence support programs in New York State. A total of 4,155 interview pairs were analyzed across three interview transitions. Multinomial models were constructed with four-category change-based independent variables (e.g., low stress at both interviews, low stress at interview 1 and high stress at interview 2, high stress at interview 1 and low stress at interview 2, high stress at both interviews) that predicted a similarly constructed four-category adherence change variable. Clients who reported positive changes in stress, substance use, or medication beliefs were more likely to change from being nonadherent to being adherent, while clients who reported negative changes were more likely to change from being adherent to being nonadherent. To improve or maintain adherence over time, strategies should be used that facilitate positive changes—and prevent negative changes—in stress, substance use, and medication beliefs.
引用
收藏
页码:1416 / 1428
页数:12
相关论文
共 183 条
[1]  
Hogg RS(1997)Triple-combination antiretroviral therapy in sub-Saharan Africa Lancet 350 1406-860
[2]  
Anis A(1998)Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators N Engl J Med 338 853-1334
[3]  
Weber AE(2000)Strategies for long-term success in the treatment of HIV infection JAMA 283 1329-51
[4]  
O’Shaughnessy MV(2007)Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapy AIDS Read 17 43-1107
[5]  
Schecter MT(1999)The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group AIDS 13 1099-363
[6]  
Palella FJ(1999)Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center J Acquir Immune Defic Syndr 22 358-30
[7]  
Delaney KM(2000)Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 21-199
[8]  
Moorman AC(2001)Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors AIDS Patient Care STDS 15 193-433
[9]  
Gallant JE(2002)Guidelines for using antiretroviral agents among HIV-infected adults and adolescents Ann Intern Med 137 381-S117
[10]  
Machtinger EL(2002)Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence J Acquir Immune Defic Syndr 31 S112-1179